New approaches to the treatment of childhood leukaemia are being developed all the time, and with this project, Owen is focusing on molecular biology. He’s developing models that can predict how certain types of the disease respond to a new set of drugs, and in the future this will improve the treatment options for all children with leukaemia.
Our funding is helping the research team use molecular biology to develop ways of seeing how leukaemia responds to new drugs, an approach that will ultimately lead to improved treatments.